1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Asia Pacific Stem Cell Therapy Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Asia Pacific Stem Cell Therapy Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Asia Pacific Stem Cell Therapy Market Regional Analysis
6.2 Asia Pacific Stem Cell Therapy Market Revenue 2020-2028 (US$ Million)
6.3 Asia Pacific Stem Cell Therapy Market Forecast Analysis
7. Asia Pacific Stem Cell Therapy Market Analysis – by Type
7.1 Adult Stem Cell Therapy
- 7.1.1 Overview
- 7.1.2 Adult Stem Cell Therapy: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.2 Embryonic Stem Cell Therapy
- 7.2.1 Overview
- 7.2.2 Embryonic Stem Cell Therapy: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.3 Induced Pluripotent Stem Cell Therapy
- 7.3.1 Overview
- 7.3.2 Induced Pluripotent Stem Cell Therapy: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.4 Other Stem Cell Therapy
- 7.4.1 Overview
- 7.4.2 Other Stem Cell Therapy: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
8. Asia Pacific Stem Cell Therapy Market Analysis – by Treatment
8.1 Allogeneic
- 8.1.1 Overview
- 8.1.2 Allogeneic: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.2 Autologous
- 8.2.1 Overview
- 8.2.2 Autologous: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
9. Asia Pacific Stem Cell Therapy Market Analysis – by Application
9.1 Musculoskeletal
- 9.1.1 Overview
- 9.1.2 Musculoskeletal: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.2 Dermatology
- 9.2.1 Overview
- 9.2.2 Dermatology: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.3 Cardiology
- 9.3.1 Overview
- 9.3.2 Cardiology: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.4 Drug Discovery & Development
- 9.4.1 Overview
- 9.4.2 Drug Discovery & Development: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.5 Other Applications
- 9.5.1 Overview
- 9.5.2 Other Applications: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
10. Asia Pacific Stem Cell Therapy Market Analysis – by End User
10.1 Hospitals & Specialty Clinics
- 10.1.1 Overview
- 10.1.2 Hospitals & Specialty Clinics: Asia Pacific Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
10.2 Academic & Research Institutes
- 10.2.1 Overview
- 10.2.2 Academic & Research Institutes : Asia Pacific Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
11. Asia Pacific Stem Cell Therapy Market – Asia-Pacific Analysis
11.1 Overview
11.2 Asia-Pacific
- 11.2.1 Asia Pacific Stem Cell Therapy Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 11.2.1.1 Asia Pacific Stem Cell Therapy Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 China:
Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.1.1 China: Asia Pacific Stem Cell Therapy Market Breakdown, by Type
- 11.2.1.1.2 China: Asia Pacific Stem Cell Therapy Market Breakdown, by Treatment
- 11.2.1.1.3 China: Asia Pacific Stem Cell Therapy Market Breakdown, by Application
- 11.2.1.1.4 China: Asia Pacific Stem Cell Therapy Market Breakdown, by End User
- 11.2.1.2 India:
Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.2.1 India: Asia Pacific Stem Cell Therapy Market Breakdown, by Type
- 11.2.1.2.2 India: Asia Pacific Stem Cell Therapy Market Breakdown, by Treatment
- 11.2.1.2.3 India: Asia Pacific Stem Cell Therapy Market Breakdown, by Application
- 11.2.1.2.4 India: Asia Pacific Stem Cell Therapy Market Breakdown, by End User
- 11.2.1.3 Japan:
Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.3.1 Japan: Asia Pacific Stem Cell Therapy Market Breakdown, by Type
- 11.2.1.3.2 Japan: Asia Pacific Stem Cell Therapy Market Breakdown, by Treatment
- 11.2.1.3.3 Japan: Asia Pacific Stem Cell Therapy Market Breakdown, by Application
- 11.2.1.3.4 Japan: Asia Pacific Stem Cell Therapy Market Breakdown, by End User
- 11.2.1.4 Australia:
Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.4.1 Australia: Asia Pacific Stem Cell Therapy Market Breakdown, by Type
- 11.2.1.4.2 Australia: Asia Pacific Stem Cell Therapy Market Breakdown, by Treatment
- 11.2.1.4.3 Australia: Asia Pacific Stem Cell Therapy Market Breakdown, by Application
- 11.2.1.4.4 Australia: Asia Pacific Stem Cell Therapy Market Breakdown, by End User
- 11.2.1.5 Rest of Asia-Pacific :
Asia Pacific Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Stem Cell Therapy Market Breakdown, by Type
- 11.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Stem Cell Therapy Market Breakdown, by Treatment
- 11.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Stem Cell Therapy Market Breakdown, by Application
- 11.2.1.5.4 Rest of Asia-Pacific : Asia Pacific Stem Cell Therapy Market Breakdown, by End User
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 MEDIPOST
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Mesoblast Limited
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 TiGenix NV
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 NuVasive Inc
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 JCR Pharmaceuticals Co. Ltd.
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations
Get Free Sample For Asia Pacific Stem Cell Therapy Market
